NASDAQ:AVEO - AVEO Pharmaceuticals News Headlines

$0.76
+0.01 (+1.33 %)
(As of 06/24/2019 04:48 AM ET)
Today's Range
$0.72
Now: $0.7646
$0.7960
50-Day Range
$0.66
MA: $0.77
$0.97
52-Week Range
$0.49
Now: $0.7646
$3.59
Volume4.69 million shs
Average Volume2.44 million shs
Market Capitalization$122.90 million
P/E RatioN/A
Dividend YieldN/A
Beta1.26

Headlines

AVEO Pharmaceuticals (NASDAQ AVEO) News Headlines

Source:
DateHeadline
AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) Given Average Rating of "Hold" by AnalystsAVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) Given Average Rating of "Hold" by Analysts
www.americanbankingnews.com - June 23 at 2:50 AM
AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) Expected to Announce Quarterly Sales of $1.77 MillionAVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) Expected to Announce Quarterly Sales of $1.77 Million
www.americanbankingnews.com - June 21 at 2:50 AM
Zacks: Analysts Expect AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) to Post -$0.06 EPSZacks: Analysts Expect AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) to Post -$0.06 EPS
www.americanbankingnews.com - June 19 at 4:22 PM
AVEO (AVEO) Down 19.9% Since Last Earnings Report: Can It Rebound?AVEO (AVEO) Down 19.9% Since Last Earnings Report: Can It Rebound?
finance.yahoo.com - June 8 at 11:44 AM
Kidney Cancer Treatment Drugs Market to See Huge Growth by 2025 | Allergan, Argos Therapeutics, AstraZeneca, Aveo Pharmaceuticals, BayerKidney Cancer Treatment Drugs Market to See Huge Growth by 2025 | Allergan, Argos Therapeutics, AstraZeneca, Aveo Pharmaceuticals, Bayer
www.marketwatch.com - May 30 at 8:28 AM
AVEO Oncology Announces Presentations at the 2019 ASCO Annual MeetingAVEO Oncology Announces Presentations at the 2019 ASCO Annual Meeting
finance.yahoo.com - May 15 at 9:00 PM
AVEO Pharmaceuticals (AVEO) Q1 Earnings & Revenues Miss MarkAVEO Pharmaceuticals (AVEO) Q1 Earnings & Revenues Miss Mark
www.nasdaq.com - May 10 at 6:55 PM
AVEO Pharmaceuticals (AVEO) Reports Q1 Loss, Tops Revenue EstimatesAVEO Pharmaceuticals (AVEO) Reports Q1 Loss, Tops Revenue Estimates
finance.yahoo.com - May 9 at 7:45 PM
AVEO Pharmaceuticals EPS in-line, beats on revenueAVEO Pharmaceuticals EPS in-line, beats on revenue
seekingalpha.com - May 9 at 8:22 AM
AVEO Reports First Quarter 2019 Financial Results and Provides Business UpdateAVEO Reports First Quarter 2019 Financial Results and Provides Business Update
finance.yahoo.com - May 9 at 8:22 AM
AVEO: 1Q Earnings SnapshotAVEO: 1Q Earnings Snapshot
finance.yahoo.com - May 9 at 8:22 AM
AVEO Pharmaceuticals (AVEO) May Report Negative Earnings: Know the Trend Ahead of Q1 ReleaseAVEO Pharmaceuticals (AVEO) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
finance.yahoo.com - May 7 at 7:00 PM
Kidney Cancer Industry: 2018 Market Research with Size, Growth, Key Players, Segments and 2023 Forecasts ResearchKidney Cancer Industry: 2018 Market Research with Size, Growth, Key Players, Segments and 2023 Forecasts Research
www.marketwatch.com - May 7 at 8:25 AM
AVEO Pharmaceuticals (AVEO) to Post Q1 Earnings: Whats Up?AVEO Pharmaceuticals (AVEO) to Post Q1 Earnings: What's Up?
finance.yahoo.com - May 1 at 8:18 AM
AVEO Oncology to Participate in the 5th Annual SunTrust Robinson Humphrey Life Sciences SummitAVEO Oncology to Participate in the 5th Annual SunTrust Robinson Humphrey Life Sciences Summit
finance.yahoo.com - May 1 at 8:18 AM
FRIDAY DEADLINE REMINDER: The Schall Law Firm Announces it is Investigating Claims Against AVEO Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmFRIDAY DEADLINE REMINDER: The Schall Law Firm Announces it is Investigating Claims Against AVEO Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
finance.yahoo.com - April 26 at 6:56 PM
APRIL 26 DEADLINE: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against AVEO Pharmaceuticals, Inc. (AVEO) and Encourages AVEO Investors Who Suffered Losses Exceeding $100,000 to Contact the FirmAPRIL 26 DEADLINE: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against AVEO Pharmaceuticals, Inc. (AVEO) and Encourages AVEO Investors Who Suffered Losses Exceeding $100,000 to Contact the Firm
feeds.benzinga.com - April 25 at 9:32 PM
FINAL DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmFINAL DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
finance.yahoo.com - April 25 at 7:17 PM
CLASS ACTION UPDATE for AVEO, AAPL and S: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of ShareholdersCLASS ACTION UPDATE for AVEO, AAPL and S: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
finance.yahoo.com - April 25 at 7:17 PM
AVEO Oncology Announces $2M Milestone Payment From EUSA Pharma Related To Commercialization of FOTIVDA ® in SpainAVEO Oncology Announces $2M Milestone Payment From EUSA Pharma Related To Commercialization of FOTIVDA ® in Spain
www.businesswire.com - April 24 at 8:21 AM
CLASS ACTION UPDATE for AVEO, DPLO and S: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of ShareholdersCLASS ACTION UPDATE for AVEO, DPLO and S: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
finance.yahoo.com - April 24 at 8:21 AM
APRIL 26 DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmAPRIL 26 DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
finance.yahoo.com - April 24 at 8:21 AM
AVEO FRIDAY DEADLINE ALERT: Rosen Law Firm Reminds AVEO Pharmaceuticals, Inc. Investors of Important April 26th Deadline in Securities Class Action Lawsuit – AVEOAVEO FRIDAY DEADLINE ALERT: Rosen Law Firm Reminds AVEO Pharmaceuticals, Inc. Investors of Important April 26th Deadline in Securities Class Action Lawsuit – AVEO
feeds.benzinga.com - April 23 at 7:54 PM
FINAL DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmFINAL DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
finance.yahoo.com - April 19 at 7:05 PM
FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of AVEO, SYNH and INGNFILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of AVEO, SYNH and INGN
finance.yahoo.com - April 19 at 7:05 PM
APR 26 DEADLINE NOTICE: Pawar Law Group Announces a Securities Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. – AVEOAPR 26 DEADLINE NOTICE: Pawar Law Group Announces a Securities Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. – AVEO
www.globenewswire.com - April 18 at 7:41 PM
AVEO Pharmaceuticals Down More Than 40% in 90 Days: Heres WhyAVEO Pharmaceuticals Down More Than 40% in 90 Days: Here's Why
finance.yahoo.com - April 18 at 7:41 PM
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Aveo Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - AVEOSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Aveo Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - AVEO
finance.yahoo.com - April 18 at 7:41 PM
Kidney Cancer Market 2018 Global Industry Size, Demand, Growth Analysis, Share, Revenue and Forecast 2023Kidney Cancer Market 2018 Global Industry Size, Demand, Growth Analysis, Share, Revenue and Forecast 2023
www.marketwatch.com - April 18 at 8:20 AM
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of AVEO, DPLO, UMC and NIOThe Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of AVEO, DPLO, UMC and NIO
feeds.benzinga.com - April 16 at 11:19 AM
AVEO Pharmaceuticals (AVEO) Dips More Than Broader Markets: What You Should KnowAVEO Pharmaceuticals (AVEO) Dips More Than Broader Markets: What You Should Know
www.nasdaq.com - April 15 at 7:25 PM
AVEO (AVEO) Up 71.1% Since Last Earnings Report: Can It Continue?AVEO (AVEO) Up 71.1% Since Last Earnings Report: Can It Continue?
finance.yahoo.com - April 13 at 5:55 PM
CLASS ACTION UPDATE for AVEO, INGN and BA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of ShareholdersCLASS ACTION UPDATE for AVEO, INGN and BA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
finance.yahoo.com - April 12 at 8:19 AM
AVEO Pharmaceuticals, Pipeline Review and Potential CatalystsAVEO Pharmaceuticals, Pipeline Review and Potential Catalysts
finance.yahoo.com - April 10 at 8:51 AM
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Aveo Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline -AVEOSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Aveo Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline -AVEO
finance.yahoo.com - April 9 at 10:16 PM
SHAREHOLDER DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmSHAREHOLDER DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
finance.yahoo.com - April 9 at 10:16 PM
AVEO Pharmaceuticals (AVEO) Outpaces Stock Market Gains: What You Should KnowAVEO Pharmaceuticals (AVEO) Outpaces Stock Market Gains: What You Should Know
finance.yahoo.com - April 8 at 7:50 PM
CLASS ACTION UPDATE for AVEO, T and CRCM: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of ShareholdersCLASS ACTION UPDATE for AVEO, T and CRCM: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
finance.yahoo.com - April 4 at 8:07 PM
AVEO Pharma down 24% after pricing equity offeringAVEO Pharma down 24% after pricing equity offering
seekingalpha.com - April 4 at 8:26 AM
AVEO Pharmaceuticals, Inc. Announces Pricing of $25 Million Underwritten Public OfferingAVEO Pharmaceuticals, Inc. Announces Pricing of $25 Million Underwritten Public Offering
www.businesswire.com - April 4 at 8:26 AM
AVEO Pharma down 23% after hours on stock offeringAVEO Pharma down 23% after hours on stock offering
seekingalpha.com - April 3 at 8:01 PM
AVEO Pharmaceuticals, Inc. Announces Proposed Public OfferingAVEO Pharmaceuticals, Inc. Announces Proposed Public Offering
finance.yahoo.com - April 3 at 8:01 PM
Aveo down 10% premarket on Fotivda authorization riskAveo down 10% premarket on Fotivda authorization risk
seekingalpha.com - April 3 at 8:19 AM
Aveo up 45% on new ficlatuzumab dataAveo up 45% on new ficlatuzumab data
seekingalpha.com - April 2 at 9:49 PM
AVEO APRIL 26th DEADLINE: Rosen Law Firm Reminds AVEO Pharmaceuticals, Inc. Investors of Important Deadline in Securities Class Action Lawsuit; Encourages Investors With Losses in Excess of $200K to Contact the Firm – AVEOAVEO APRIL 26th DEADLINE: Rosen Law Firm Reminds AVEO Pharmaceuticals, Inc. Investors of Important Deadline in Securities Class Action Lawsuit; Encourages Investors With Losses in Excess of $200K to Contact the Firm – AVEO
finance.yahoo.com - April 2 at 9:49 PM
AVEO Oncology to Present at the H.C. Wainwright Global Life Sciences ConferenceAVEO Oncology to Present at the H.C. Wainwright Global Life Sciences Conference
finance.yahoo.com - April 2 at 8:40 AM
AVEO +22.5% after positive results from AML trialAVEO +22.5% after positive results from AML trial
seekingalpha.com - April 1 at 7:57 PM
AVEO and Biodesix Announce Positive Results from Phase Ib Ficlatuzumab-Cytarabine Trial in Patients with Relapsed and Refractory AMLAVEO and Biodesix Announce Positive Results from Phase Ib Ficlatuzumab-Cytarabine Trial in Patients with Relapsed and Refractory AML
finance.yahoo.com - April 1 at 7:57 PM
APRIL DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmAPRIL DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
finance.yahoo.com - March 30 at 8:19 AM
Thinking about buying stock in Aveo Pharmaceuticals, Lululemon Athletica Inc., Navios Maritime, Quantenna Communications Inc., or Reebonz Ltd.?Thinking about buying stock in Aveo Pharmaceuticals, Lululemon Athletica Inc., Navios Maritime, Quantenna Communications Inc., or Reebonz Ltd.?
www.marketwatch.com - March 28 at 7:26 PM
This page was last updated on 6/24/2019 by MarketBeat.com Staff

Featured Article: The risks of owning bonds

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel